(Reuters) -German pharmaceutical and biotechnology group Bayer said on Thursday it had set aside an additional 1.2 billion ...

Bayer (BAYRY) stock gains as the company raises 2025 financial outlook, citing strong pharma performance. Read more here.

In a separate study, an implant containing a different investigational endothelin antagonist (PER-001) reduced macular ...

The German pharmaceutical and agricultural conglomerate said it now expects to post revenue of more than $52.51 billion for ...

Bayer, the biotech company and manufacturer of Round Up, has substantially increased its spending on lobbying in Iowa since ...

GERMAN pharmaceutical and biotechnology group Bayer said on Thursday it had set aside an additional 1.2 billion euros ($1.37 ...

As leaked by Footy Headlines, the 2025/26 Chelsea third kit design has emerged ahead of its official release. The kid is ...

Ardon Jashari will reportedly demand Club Brugge release him to Milan this weekend, refusing to accept higher offers from ...

Liverpool are busy trying to add Alexander Isak to their already star-studded squad. It’s been a transfer window like no ...

German pharmaceutical and agricultural chemicals giant Bayer said it had put aside an extra 1.2 billion euros ($1.4 billion) ...

Fabrizio Romano Confirms £15m DealAfter a record-breaking start to the summer window in terms of arrivals, Liverpool’s ...

Liverpool midfielder Tyler Morton is close to securing a move to Lyon for a deal worth around £15 million inclusive of ...